A detailed history of Huntington National Bank transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Huntington National Bank holds 611 shares of FLGT stock, worth $12,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
611
Previous 611 -0.0%
Holding current value
$12,299
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$21.55 - $29.29 $215 - $292
10 Added 1.66%
611 $13,000
Q3 2021

Oct 28, 2021

SELL
$74.87 - $110.87 $15,273 - $22,617
-204 Reduced 25.34%
601 $54,000
Q2 2021

Jul 30, 2021

BUY
$66.8 - $100.45 $5,277 - $7,935
79 Added 10.88%
805 $74,000
Q1 2021

Apr 12, 2021

BUY
$59.3 - $183.85 $7,412 - $22,981
125 Added 20.8%
726 $70,000
Q2 2020

Jul 30, 2020

BUY
$8.89 - $18.28 $5,342 - $10,986
601 New
601 $10,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.